Welcome & Introducation

Urothelial cancer Urinary bladder Cancer

Neoadjuvant Immunotherapy in advanced Bladder Cancer

Oncology as On Today Essence of ESMO WCLC 2022 | Welcome & Introduction

IMpower010 : Updated data of phase III Trial of adjuvant Atezolizumab vs BSC in Resected State IB-IIA NSCLC After adjuvant Chemotherapy

Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable lung cancer the INCREASE trial

Welcome & Introduction

Unleashing the Controversy : LHRH Agonists & LHRH Antagonists

Prostate Cancer Patient Journey MDT approach and GETUG AFU-16

GI Cancer Update | Welcome & Introduction

Clinical management of GI Cancers through the lens of Comprehensive Genomic Profiling

Metastatic Gastric Cancer

Clinical Updates in the Management of Genito Urinary | Welcome & Introduction

Neoadjuvant/adjuvant in UTTCC when & where

Evolution of treating urothelial cancer how far have we come